JPMorgan Annual Meeting votes: directors elected, all proposals defeated

JPMORGAN CHASE & CO

All 11 director nominees elected with at least 92.37% support; James Dimon and others reelected.
Say-on-pay approved with 92.35% of votes; auditor PwC ratified with 92.79%.
Seven shareholder proposals defeated; independent board chairman proposal received 35.11% support.
2.28 billion shares (85.17% of outstanding) were represented at the meeting.

item 5.07 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0000019617-26-000228
form_type: 8-K
ticker: JPM
cik: 0000019617
company_name: JPMORGAN CHASE & CO
filed_at: 2026-05-21T20:15:13+00:00
discovered_at: 2026-05-21T20:16:00.107226+00:00
generated_at: 2026-05-21T20:18:04.971717+00:00
sec_items: ["5.07", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.35
calibrated_materiality_score: 0.15
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0000019617-26-000228
json_url: https://secwatch.observer/filing/0000019617-26-000228.json
markdown_url: https://secwatch.observer/filing/0000019617-26-000228.md
text_url: https://secwatch.observer/filing/0000019617-26-000228.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/19617/000001961726000228/0000019617-26-000228-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/19617/000001961726000228/jpm-20260519.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

SYRE

Spyre Therapeutics stockholders approve amended ESPP; director Peter Harwin resigns

Spyre Therapeutics, Inc. May 29, 2026, 4:45 PM ET other_material Items 5.02, 5.07, 9.01

same SEC item: 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

FFAI

Faraday Future signs 23-unit robot order, first healthcare delivery; annual meeting passed with 80% support

FARADAY FUTURE INTELLIGENT ELECTRIC INC. May 29, 2026, 4:15 PM ET other_material Items 5.07, 9.01

same SEC item: 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

AHRT

AH Realty Trust releases Q1 2026 investor presentation for meetings starting June 1

AH Realty Trust, Inc. June 1, 2026, 4:05 PM ET other_material Items 7.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

ACDC

ProFrac shareholders elect all six director nominees, approve say-on-pay

ProFrac Holding Corp. June 1, 2026, 4:02 PM ET other_material Items 5.07

same SEC item: 5.07 same event type: other_material similar materiality

Filing page SEC filing

KROS

Keros CEO to present at Goldman Sachs healthcare conference June 8

Keros Therapeutics, Inc. June 1, 2026, 4:02 PM ET other_material Items 7.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

HNVR

Shareholders elect three directors, approve equity plan, ratify auditor at annual meeting

Hanover Bancorp, Inc. /MD June 1, 2026, 4:00 PM ET other_material Items 5.02, 5.07

same SEC item: 5.07 same event type: other_material similar materiality

Filing page SEC filing

US Alliance Corp

US Alliance Corp stockholders re-elect all five directors and ratify Crowe LLP at annual meeting

US Alliance Corp June 1, 2026, 3:28 PM ET other_material Items 5.07

same SEC item: 5.07 same event type: other_material similar materiality

Filing page SEC filing

REGENCY CENTERS LP

Regency Centers releases updated investor presentation for conferences

REGENCY CENTERS LP June 1, 2026, 3:24 PM ET other_material Items 7.01, 9.01

same SEC item: 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0000019617-26-000228

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.